MarginsXMarginsX
Home › Markets › Health Care › SIBN

SI-BONE Inc. (SIBN)

SIBN trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$23.41
-0.13% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$200.9M
+20.2% on 2024
Net income · 2025
-$18.9M
-9.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1459839/000145983926000036/0001459839-26-000036-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSIBN on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2018
SEC CIK0001459839
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$200.9M
Net income-$18.9M
Operating income-$22.3M
Net margin-9.4%
Operating margin-11.1%
Revenue growth+20.2%
Cash$42.2M
Total assets$238.6M
P/E (computed)Net income was not positive
P/S (computed)5.3×

Warning signs

Cash runway
Cash-flow positive
$35.3M cash at September 30, 2026
Share count, 1 year
+4.0%
2025-11-04 to 2026-10-28 · +11.4% over 3 years
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
-$10.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$35.3M cash; operating cash flow $1.5M a quarter.Report 2026-09-30
Shares outstanding45,113,087 (2026-10-28); 43,391,254 a year earlier; 40,501,023 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-24
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $10.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$55.7M-$3.6M$5.9M$35.3M$35.7M$220.7M10-Q 2026-11-03
Q2 2026
2026-06-30
$56.0M-$4.1M$777K$33.1M$35.6M$213.6M10-Q 2026-08-04
Q1 2026
2026-03-31
$52.6M-$4.3M-$2.4M$33.5M$35.6M$206.2M10-Q 2026-05-11
Q4 2025
2025-12-31
$56.3M-$1.6M$1.7M$42.2M$35.6M$200.9M10-K 2026-02-24
Q3 2025
2025-09-30
$48.7M-$4.6M$2.3M$26.5M$35.5M$193.6M10-Q 2026-11-03
Q2 2025
2025-06-30
$48.6M-$6.2M$173K$34.1M$35.5M$185.3M10-Q 2026-08-04
Q1 2025
2025-03-31
$47.3M-$6.5M-$4.9M$41.2M$35.5M$176.6M10-Q 2026-05-11
Q4 2024
2024-12-31
$49.0M-$4.5M$1.2M$34.9M$35.5M$167.2M10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-02-24
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-04-21

Source: SEC EDGAR submissions feed, 787 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.3%
1 month+19.1%
3 months+23.7%
Year to date+18.9%
1 year+35.8%
From 52-week high-8.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
AORTArtivion Inc.$18.47-3.30%$901.1M
BVSBioventus Inc.$10.46-1.88%$881.4M
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier